Prestige Brands Holdings, Inc. (NYSE) · Transaction Feb 13, 2015 · Filed Feb 26, 2015 · $1,001 to $15,000
Prestige Consumer Healthcare Inc
Veridion Score
BETAHIGH CONF · 6/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is PBH moving today?
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
PBH overview
Related filings and maps
Congress activity in PBH
PBH contract awards, year to date.
Public federal awards linked to this ticker.
PBH lobbying filings, year to date.
Registered lobbying filings matched to Prestige Consumer Healthcare Inc.